LCI: [4-[[4-[5-(cyclopropylmethyl)-1-methyl-pyrazol-4-yl]-5-fluoranyl-pyrimidin-2-yl]amino]cyclohexyl]azanium
LCI is a Ligand Of Interest in 6GZM designated by the Author
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 6GZM_LCI_B_1003 | 90% | 20% | 0.091 | 0.972 | 1.32 | 2.02 | 4 | 10 | 0 | 0 | 100% | 1 |
| 6GZM_LCI_A_1004 | 73% | 18% | 0.12 | 0.947 | 1.6 | 1.93 | 5 | 7 | 0 | 0 | 100% | 0.7 |
| 6GZD_LCI_A_1018 | 65% | 12% | 0.121 | 0.921 | 1.6 | 2.4 | 4 | 12 | 0 | 0 | 100% | 1 |
| 6GZH_LCI_A_2001 | 54% | 13% | 0.197 | 0.964 | 1.56 | 2.34 | 3 | 10 | 1 | 0 | 100% | 1 |
